Pure Global

A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs) - Trial NCT05905458

Access comprehensive clinical trial information for NCT05905458 through Pure Global AI's free database. This Phase 2 trial is sponsored by Chengdu Suncadia Medicine Co., Ltd. and is currently Not yet recruiting. The study focuses on Chronic Hepatitis B. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05905458
Phase 2
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT05905458
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-designed Phase II Study to Evaluate the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Study Focus

Chronic Hepatitis B

HRS9950 tablets

Interventional

drug

Sponsor & Location

Chengdu Suncadia Medicine Co., Ltd.

Timeline & Enrollment

Phase 2

Aug 01, 2023

Jan 25, 2025

50 participants

Primary Outcome

Change in mean log10 serum hepatitis B surface antigen levels from baseline to week 24

Summary

To evaluate the efficacy and safety of HRS9950 tablets in chronic hepatitis B patients who
 are virologically suppressed on nucleoside or nucleotide analogues (NAs).

ICD-10 Classifications

Acute hepatitis B
Chronic viral hepatitis B without delta-agent
Acute delta-(super)infection in chronic hepatitis B
Chronic viral hepatitis B without delta-agent : other and unspecified phase
Chronic viral hepatitis B without delta-agent : immune-tolerant phase

Data Source

ClinicalTrials.gov

NCT05905458

Non-Device Trial